UTHR | United Therapeutics Corp |
Pharmaceutical Preparations |
Book value per $ invested | $ 0.37 |
Leverage | 14.35% |
Market Cap | $ 16.6B |
PE | 15.05 |
Dividend Yield | 0.00% |
Profit | $ 1.1B |
Margin | 40.43% |
United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company is headquartered in Silver Spring, Maryland.